ELS - Draft Pricing Tables.xlsx

XLSX spreadsheet 27 KB Posted

Attached to
Polymerase Chain Reaction (PCR) COVID-19 Testing Support Federal contract opportunity
Solicitation number
19AQMM20R0309
Issued by
Department of State Office of Acquisition Management

About this file

This notice provides information on an upcoming solicitation for Polymerase Chain Reaction (PCR) COVID-19 testing support services. The U.S. Department of State Bureau of Medical Services requires a CLIA-certified laboratory to support on-site and off-premises specimen collection and processing for laboratory tests in the National Capital Region. Services will include on-site biological specimen collection and transportation, as well as reverse transcriptase PCR testing for SARS-CoV-2 virus including collection of specimens. The anticipated one-year base period and four one-year option periods, plus a six-month extension, will utilize firm-fixed-price and firm-fixed-unit-price contract line items. The 100% small business set-aside solicitation is expected to be released between August 24-28, utilizing best value tradeoff evaluation. Technical merit is more important than price. The notice provides draft pricing tables and requests relevant experience from potential offerors.

View the file

Other files for this federal contract opportunity

Other files attached to Polymerase Chain Reaction (PCR) COVID-19 Testing Support, newest first.
File Type Posted
ELS - Draft Relevant Experience Questionnaire.docx DOCX document
ELS - Draft Performance Work Statement.docx DOCX document

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

1. NTE Profit Percentages Pricing Table 1

Proposed Not-to-Exceed (NTE) Profit Percentages

Proposed Not-to-Exceed (NTE) Profit Percentages
Base PeriodOption Year 1Option Year 2Option Year 3Option Year 4Option Year 5Six-Month Option to Extend
0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Notes
1) Offerors shall propose one profit percentage per contract year
2) The proposed profit percentages shall not exceed two decimal places

2. IDIQ Prices Pricing Table 2 Enhanced Laboratory Support Services

CLIN Description Base Year Option Year 1 Option Year 2 Option Year 3 Option Year 4 Six-Month Option (FAR 52.217-8) Total

NTE Price per Task Order, per dayQuantitySubtotalNTE Price per Task Order, per dayQuantitySubtotalNTE Price per Task Order, per dayQuantitySubtotalNTE Price per Task Order, per dayQuantitySubtotalNTE Price per Task Order, per dayQuantitySubtotalNTE Price per Task Order, per dayQuantitySubtotal
X001On-Site Biological Specimen Collection (2401 E St NW

Washington DC) biological specimen collection and transportation of specimens to the Contractor's processing location for 180 personnel being tested (includes all labor costs, other direct costs, applicable indirect costs, profit/fee) 365 - 365 - 365 - 365 - 365 - 183 - -

NTE Price per TestQuantitySubtotalNTE Price per ApplicantQuantitySubtotalNTE Price per ApplicantQuantitySubtotalNTE Price per ApplicantQuantitySubtotalNTE Price per ApplicantQuantitySubtotalNTE Price per ApplicantQuantitySubtotal
X0002Reverse Transcriptase PCR Testing for SARS-CoV-2 Virus.

Includes collection of necessary biological specimens at the Contractor's processing location (includes all labor costs, other direct costs, applicable indirect costs, profit/fee) 131,400 - 131,400 - 131,400 - 131,400 - 131,400 - 65,700 - -

Total - - - - - -

OVERALL PROPOSED PRICE -

Notes:
1) Offerors shall propose one not-to-exceed (NTE) unit price per contract period for each CLIN
2) Offerors shall not alter the Excel sheet in any way other than to fill out the yellow-highlighted areas
3) Quantity (CLIN X001) = RFP-specified estimated number of days that on-site biological specimen collection will occur
4) Quantity (CLIN X0002) = RFP-specified estimated number of Reverse Transcriptase PCR tests for SARS-CoV-2 virus

File details come from the government source that posted it. Updated .